Dendritic cells stimulate the expansion of PML-RARα specific cytotoxic T-lymphocytes: Its applicability for antileukemia immunotherapy

Journal of Experimental and Clinical Cancer Research

Volumn 18, Issue 4, 1999, Pages 485-492

  Osman, Y ^a   Takahashi, M ^a,b   Zheng, Z ^a   Toba, K ^a   Liu, A ^a   Furukawa, T ^a   Narita, M ^a   Aizawa, Y ^a   Koike, T ^b   Shibata, A ^c  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c Tachikawa General Hospital   (Japan)

Author keywords

Acute promyelocytic leukemia; Cytotoxic T lymphocytes; Dendritic cells; Immunotherapy; PML RAR

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RETINOIC ACID RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOPHENOTYPING; IMMUNOTHERAPY; LEUKEMIA, PROMYELOCYTIC, ACUTE; MACROPHAGES; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033493099     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Rowley J.D., Golomb H.M., Dougherty C.: 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia (letter). Lancet 1: 549, 1997.
2. Borrow J., Goddard A.D., Sheer D., Solomon E.: Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 249:1577, 1990.
3. de The H., Chomienne C., Lanotte M., Degos L., Dejean A.: The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347: 558, 1990.
4. Alcalay M., Zangrilli D., Pandolfi P.P., Longo L., Mencarelli A., Giacomucci A., Rocchi M., Biondi A., Rambaldi A., Lo Coco F., Diverio D., Donti E., Grignani F., Pelicci P.G.: Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor alpha locus. Proc. Natl. Acad. Sci USA 88: 1977, 1991.
5. Goddard A.D., Borrow J., Freemont P.S., Solomon E.: Characterization of a novel zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 254: 1371, 1991.
6. Kakizuka A., Miller W.H. Jr., Umesono K., Warrell R.P. Jr., Frankel S.R., Murty V.V., Dmitrovsky E., Evans R.M.: Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66: 663, 1991
7. de The H., Lavau C., Marchio A., Chomienne C., Degos L., Dejean A.: The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66: 675, 1991.
8. Kastner P., Perez A., Lutz Y., Rochette-Egly C., Gaub M.P., Durand B., Lanotte M., Berger R., Chambon P.: Structure, localization and transcriptional properties of two classes of retinoic acid receptor α fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J. 11: 629, 1992.
9. Dyck J.A., Maul G.G., Miller W.H. Jr., Chen J.D., Kakizuka A., Evans R.M.: A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76: 333, 1994.
10. Weis K., Rambaud S., Lavau C., Jansen J., Carvalho T., Carmo-Fonseca M., Lamond A., Dejean A.: Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells. Cell 76: 345, 1994.
11. Hsu F.J., Benike C., Fagnoni F., Liles T.M., Czerwinski D., Taidi B., Engleman E.G., Levy R.: Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med. 2: 52, 1996.
12. Mayordomo J.I., Zorina T., Storkus W.J., Zitvogel L., Celluzzi C., Falo L.D., Melief C.J., Ildstad S.T., Kast W.M., Deleo A.B., Lotze M.T.: Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumour immunity. Nature Med. 1: 1297, 1995.
13. Grabbe S., Beissert S., Schwartz T., Granstein R.D.: Dendritic cells as initiators of tumor immune response: A possible strategy for immunotherapy. Immunol. Today 16: 117, 1995.
14. Steinman R.M.: The dendritic cell system and its role in immunogenicity. Ann. Rev. Immunol. 9: 271, 1991.
15. Murphy G., Tjoa B., Ragde H., Kenny G., Boynton A.: Phase 1 clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen. The prostate 29: 371, 1996.
16. Wen Y.J., Ling M., Bailey-Wood R., Lim S.H.: Idiotypic protein-pulsed adherent peripheral blood mononuclear cell-derived dendritic cells prime immune system in multiple myeloma. Clin. Cancer Res. 4: 957, 1998.
17. Nestle F.O., Alijagic S., Gilliet M., Sun Y., Grabbe S., Dummer R., Burg G., Schadendorf D.: Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nature Med. 4: 328, 1998.
18. Choudhury A., Gajewski J.L., Liang J.C., Popat U., Claxton D.F., Kliche K.O., Andreeff M., Champlin R.E.: Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 89: 1133, 1997.
19. Mannering S.I., McKenzie J.L., Fearnley D.B., Hart D.N.J.: HLA-DR1-restricted bcr-abl (b3a2)-specific CD4+ T lymphocytes respond to dendritic cells pulsed with b3a2 peptide and antigen-presenting cells exposed to b3a2 containing cell lysates. Blood 90: 290, 1997.
20. Oettel K.R., Welsy O.H., Albertini M.R., Hank J.A., Lliopolis O., Sosman J.A., Voelkerding K., Wu S.Q., Clark S.S., Sondel P.M.: Allogeneic T-cell clones able to selectively destroy Philadelphia chromosome-bearing (Ph1+) human leukemia lines can also recognize Ph1-cells from the same patient. Blood 83: 3390, 1994.
21. Toba K., Koike T., Takahashi M., Kishi K., Hashimoto S., Takahashi H., Uesugi Y., Ishikawa T., Aoki S., Maeo S., Naito M., Aizawa Y., Shibata A.: Characterization and sensitivity to interleukin 2 and interferon α of leukemic cells from a patient with large granular lymphocytic leukemia associated with chronic active Epstein-Barr virus infection. Leuk. Res. 21: 941, 1997.
22. Gambacorti-Passerini C., Grignani F., Arienti F., Pandolfi P.P., Pelicci P.G., Parmiani G.: Human CD4 lymphocytes specifically recognize a peptide representing the fusion region of the hybrid protein pml/RARα present in acute promyelocytic leukemia cells. Blood 81: 1369, 1993.
23. Gausepohl H., Boulin C., Kraft M., Boulin C., Frank R.W.: Automated multiple peptide synthesis. Pept. Res. 5: 315, 1992.
24. Tsai V., Kawashima I., Keogh E., Daly K., Alessandro S., Celis E.: In vitro immunization and expansion of antigen-specific cytotoxic T lymphocytes for adoptive immunotherapy using peptide-pulsed dendritic cells. Crit. Rev. Immunol. 18: 65, 1998.
25. Ostankovitch M., Buzyn A., Bonhomme D., Connan F., Bouscary D., Heshmati F., Dreyfus F., Choppin J., Guillet J.G.: Antileukemic HLA-restricted T-cell clones generated with naturally processed peptides eluted from acute myeloblastic leukemia blasts. Blood 92: 19, 1998.
26. Uchida A., Micksche M.: Lysis of fresh human tumor cells by autologous large granular lymphocytes from peripheral blood and pleural effusions. Int. J. Cancer 32: 37, 1983.
27. Levin D., Constant S., Pasqualini T., Flavell R., Bttomly K.: Role of dendritic cells in the priming of CD4+ T lymphocytes to peptide antigen in vivo. J Immunol 151: 6742, 1993.
28. Steinman R.M., Witmer-Pack M., Inaba K.: Dendritic cells: Antigen presentation, accessory function and clinical relevance. Adv. Exp. Med. Biol. 329: 1, 1993.
29. Caux C., Liu Y.J., Banchereau J.: Recent advances in the study of dendritic cells and follicular dendritic cells. Immunol. Today 16: 2, 1995.
30. Zhou L.J., Tedder T.F.: Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 154: 3821, 1995.
31. Nunez R., Sanchez M., Wild P., Filgueira L., Nunez C.: Characterisation of two human dendritic cell-lines that express CD1a, take-up, process and present soluble antigens and induce MLR. Immunology letters 61: 33, 1998.